HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating for Precision BioSciences (NASDAQ:DTIL) and maintained a price target of $60, indicating confidence in the company's future performance.
August 22, 2024 | 4:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Precision BioSciences and maintained a $60 price target, suggesting strong confidence in the company's potential growth.
The reiteration of a Buy rating and a high price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100